Scientists have identified a protein that appears to put the brakes on the chronic inflammation linked to aging. Older mice ...
Infex Therapeutics announces positive phase IIa study results for RESP-X in NCFB patients colonised with Pseudomonas aeruginosa: Cheshire, UK Saturday, May 23, 2026, 18:00 Hrs [IS ...
ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in ...
AI-mediated discovery has fundamentally changed who shows up to your website and what they expect when they get there.
In a clear sign that California is not facing water shortages or a drought this summer, Lake Oroville, the state’s ...
Coffee may give your blood pressure a temporary jolt, but that doesn’t mean it’s secretly wrecking your heart. Researchers ...
Keir Starmer, Britain's first Labour prime minister in 14 years, is fighting for his political life as mainstream parties ...
Phase 1 Clinical Data Demonstrate Dose-Proportional PK, No Dose-Limiting Toxicities Through Four Dose Levels, and Concordance with Preclinical ...
AI won't take your job. An AI-native human will. Here's what separates those who thrive from those who get displaced.
Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company advancing next-generation, long-acting bispecific antibodies for immunology and inflammation, today announced ...
It's hard to find quality that endures from beginning to end, but that's exactly what you'll get in these action-packed first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results